Use of ketogenic compounds for treatment of age-associated memory impairment
First Claim
1. A method of treatment for Age-Associated Memory Impairment (AAMI), comprising the steps of:
- identifying a mammal having, or at risk of AAMI; and
administering to the mammal a composition comprising medium chain triglycerides (MCT) of the formula;
3 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to the field of therapeutic agents for the treatment of Age-Associated Memory Impairment (AAMI). In particular, the present invention utilizes compositions comprising at least one compound capable of elevating ketone body concentrations in a mammal (e.g., ketogenic compounds), administered in an amount effective for treatment or prevention of loss of cognitive function caused by reduced neuronal metabolism in AAMI. In one embodiment, the composition includes medium chain triglycerides (MCT). In another embodiment, the compositions are administered in the presence of carbohydrate. The present invention also relates to oral dosage forms, in particular, a nutritional drink comprising at least one compound capable of elevating ketone body concentrations in a mammal.
-
Citations
22 Claims
-
1. A method of treatment for Age-Associated Memory Impairment (AAMI), comprising the steps of:
-
identifying a mammal having, or at risk of AAMI; and administering to the mammal a composition comprising medium chain triglycerides (MCT) of the formula; - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
-
Specification